發(fā)布時間：2018-06-04 23:23

  本文選題：Cirrhotic + cardiomyopathy��； 參考：《World Journal of Gastroenterology》2015年41期

【摘要】：During the course of cirrhosis, there is a progressive deterioration of cardiac function manifested by the disappearance of the hyperdynamic circulation due to afailure in heart function with decreased cardiac output. This is due to a deterioration in inotropic and chronotropic function which takes place in parallel with a diastolic dysfunction and cardiac hypertrophy in the absence of other known cardiac disease. Other findings of this specific cardiomyopathy include impaired contractile responsiveness to stress stimuli and electrophysiological abnormalities with prolonged QT interval. The pathogenic mechanisms of cirrhotic cardiomyopathy include impairment of the b-adrenergic receptor signalling, abnormal cardiomyocyte membrane lipid composition and biophysical properties, ion channel defects and overactivity of humoral cardiodepressant factors. Cirrhotic cardiomyopathy may be difficult to determine due to the lack of a specific diagnosis test. However, an echocardiogram allows the detection of the diastolic dysfunction and the E/e′ ratio may be used in the followup progression of the illness. Cirrhotic cardiomyopathy plays an important role in the pathogenesis of the impairment of effective arterial blood volume and correlates with the degree of liver failure. A clinical consequence of cardiac dysfunction is an inadequate cardiac response in the setting of vascular stress that may result in renal hypoperfusion leading to renal failure. The prognosis is difficult to establish but the severity of diastolic dysfunction may be a marker of mortality risk. Treatment is non-specific and liver transplantation may normalize the cardiac function.
[Abstract]:During the course of cirrhosis, there is a progressive deterioration of cardiac function manifested by the disappearance of the hyperdynamic circulation due to afailure in heart function with decreased cardiac output. This is due to a deterioration in inotropic and chronotropic function which takes place in parallel with a diastolic dysfunction and cardiac hypertrophy in the absence of other known cardiac disease. Other findings of this specific cardiomyopathy include impaired contractile responsiveness to stress stimuli and electrophysiological abnormalities with prolonged QT interval. The pathogenic mechanisms of cirrhotic cardiomyopathy include impairment of the b-adrenergic receptor signalling, abnormal cardiomyocyte membrane lipid composition and biophysical properties, ion channel defects and overactivity of humoral cardiodepressant factors. Cirrhotic cardiomyopathy may be difficult to determine due to the lack of a specific diagnosis test. However, an echocardiogram allows the detection of the diastolic dysfunction and the E / E'ratio may be used in the followup progression of the illness. Cirrhotic cardiomyopathy plays an important role in the pathogenesis of the impairment of effective arterial blood volume and correlates with the degree of liver failure. A clinical consequence of cardiac dysfunction is an inadequate cardiac response in the setting of vascular stress that may result in renal hypoperfusion leading to renal failure. The prognosis is difficult to establish but the severity of diastolic dysfunction may be a marker of mortality risk. Treatment is non-specific and liver transplantation may normalize the cardiac function.
【作者單位】： Hepatic
【基金】：Supported by Grants from Fondo de Investigaciones Sanitarias(FIS 06/1082,in part)
【分類號】：R575.2;R542.2

【參考文獻】

相關(guān)期刊論文 前4條

1 Anca Trifan;Stefan Chiriac;Carol Stanciu;;Update on adrenal insufficiency in patients with liver cirrhosis[J];World Journal of Gastroenterology;2013年04期

2 Zankhana Raval;Matthew E Harinstein;James D Flaherty;;Role of cardiovascular intervention as a bridge to liver transplantation[J];World Journal of Gastroenterology;2014年31期

3 Natig Gassanov;Evren Caglayan;Nasser Semmo;Gero Massenkeil;Fikret Er;;Cirrhotic cardiomyopathy:A cardiologist's perspective[J];World Journal of Gastroenterology;2014年42期

4 S?ren M?ller;Jens H Henriksen;Flemming Bendtsen;;Extrahepatic complications to cirrhosis and portal hypertension: Haemodynamic and homeostatic aspects[J];World Journal of Gastroenterology;2014年42期

【共引文獻】

相關(guān)期刊論文 前10條

1 曹中靜;宋治遠;舒茂琴;冉擘力;鐘理;蔣周芩;鄧盛榮;李華康;;特發(fā)性室性早搏負荷及起源位置對左心功能的影響[J];第三軍醫(yī)大學學報;2013年22期

2 Hua Mao;Deng-feng Jiang;Li-yun Huang;;The Serum NT-proBNP in Patients with Cirrhosis:Relationship to Cardiac Dysfunction and Liver Function[J];Infection International(Electronic Edition);2013年01期

3 趙啟慧;侯義龍;;植物天然藥用成分研究進展[J];中國城市林業(yè);2014年01期

4 劉鋤非;周力;陳曉琴;;肝硬化心肌病研究進展[J];貴州醫(yī)藥;2014年04期

5 臧紅;辛紹杰;;終末期肝病相關(guān)并發(fā)癥的管理和規(guī)范診治[J];傳染病信息;2014年02期

6 唐媚;胡松;唐信威;劉陽;王衍堂;鄒強;;成纖維樣滑膜細胞Toll樣受體在類風濕性關(guān)節(jié)炎的研究進展[J];成都醫(yī)學院學報;2014年02期

7 馮世杰;宗英;張子騰;杜秀明;袁伯俊;陸國才;;NLRP3基因敲除小鼠的繁殖與基因型鑒定[J];第二軍醫(yī)大學學報;2014年05期

8 孫學強;張晨光;毛志方;;安妥沙星治療自發(fā)性腹膜炎的療效和安全性觀察[J];蚌埠醫(yī)學院學報;2014年05期

9 徐美蘭;劉金星;;Sap2蛋白與樹突狀細胞對系統(tǒng)性白假絲酵母菌感染的免疫保護性[J];南方醫(yī)科大學學報;2014年07期

10 羅鈞元;張浩;;特利加壓素在預防腹腔穿刺術(shù)后循環(huán)功能障礙中的作用[J];保健醫(yī)學研究與實踐;2014年04期

相關(guān)博士學位論文 前10條

1 黃冰生;40mg與10mg阿托伐他汀對缺血性心肌病患者外周血循環(huán)內(nèi)皮微顆粒、內(nèi)皮祖細胞、心肌能量消耗及左室功能影響的比較[D];南方醫(yī)科大學;2012年

2 畢麗麗;豬溶素誘導宿主產(chǎn)生炎癥因子的分子機制研究[D];中國人民解放軍軍事醫(yī)學科學院;2013年

3 林瓊雯;實時三維超聲心動圖評價穩(wěn)定性冠心病患者左心室舒張功能的研究[D];北京協(xié)和醫(yī)學院;2013年

4 章璐;成人多發(fā)性肌炎/皮肌炎伴發(fā)心臟損害的臨床研究[D];北京協(xié)和醫(yī)學院;2013年

5 劉楠;Apelin對缺血—再灌注損傷導致的心臟功能障礙的保護作用及機制研究[D];第四軍醫(yī)大學;2013年

6 宋爽;PRRSV誘導炎癥反應及其調(diào)控機制[D];華中農(nóng)業(yè)大學;2013年

7 張碩;兩種降壓方案對高血壓患者左室舒張功能的影響[D];中南大學;2013年

8 楊國紅;逆轉(zhuǎn)錄病毒中介的VEGF-C/VEGFR-3信號通路調(diào)節(jié)對高鹽攝入誘導的高血壓性左心室重塑的干預作用[D];天津醫(yī)科大學;2013年

9 劉芳;骨髓間充質(zhì)干細胞移植聯(lián)合雌激素治療宮腔粘連的實驗研究[D];南方醫(yī)科大學;2013年

10 黃傳業(yè);耐力運動后心肌肌鈣蛋白T釋放規(guī)律、機制及其與心肌重塑關(guān)系的研究[D];上海體育學院;2013年

相關(guān)碩士學位論文 前10條

1 江登豐;肝硬化患者心功能改變研究及其影響因素分析[D];南方醫(yī)科大學;2012年

2 侯蘇蕓;左房追蹤技術(shù)與實時全容積三維超聲評價肥厚型心肌病患者左心房功能[D];鄭州大學;2013年

3 牛福英;單心動周期實時三維超聲心動圖評價擴張型心肌病心衰患者左室形態(tài)、功能及同步性的研究[D];河北醫(yī)科大學;2013年

4 周瑩瑩;左室壁舒張期運動的不一致性對評判冠心病心肌缺血的價值研究[D];廣西醫(yī)科大學;2013年

5 高歌;原發(fā)性高血壓患者的心房電機械時間、P波離散度與E/Ea的相關(guān)性研究[D];遵義醫(yī)學院;2013年

6 張莎莎;夏天無注射液對缺血再灌注大鼠腦組織NF-κB信號通路影響的研究[D];遵義醫(yī)學院;2013年

7 李同;高鹽飲食對Wistar大鼠血壓和左室重構(gòu)的影響及替米沙坦和辣椒素干預作用[D];遵義醫(yī)學院;2013年

8 劉燕;高鹽飲食對大鼠血壓和腎臟的影響及替米沙坦和辣椒素的干預作用[D];遵義醫(yī)學院;2013年

9 李穎;肝硬化患者心臟功能及血漿B型利鈉肽水平的臨床研究[D];大連醫(yī)科大學;2012年

10 李藝;左心室舒張功能不全與肺動脈高壓的相關(guān)性研究[D];大連醫(yī)科大學;2012年

【二級參考文獻】

相關(guān)期刊論文 前6條

1 ;Cardiac arrest after graft reperfusion during liver transplantation[J];Hepatobiliary & Pancreatic Diseases International;2006年02期

2 ;Postreperfusion syndrome during orthotopic liver transplantation:a single-center experience[J];Hepatobiliary & Pancreatic Diseases International;2012年01期

3 SφrenMφller;JensHHenriksen;;Cardiopulmonary,complications in chronic liver disease[J];World Journal of Gastroenterology;2006年04期

4 SeyedAliGaskari;SamuelSLee;;Cardiac and vascular changes in cirrhosis:Pathogenic mechanisms[J];World Journal of Gastroenterology;2006年06期

5 Gyongyi Szabo;Shashi Bala;;Alcoholic liver disease and the gut-liver axis[J];World Journal of Gastroenterology;2010年11期

6 Anca Trifan;Stefan Chiriac;Carol Stanciu;;Update on adrenal insufficiency in patients with liver cirrhosis[J];World Journal of Gastroenterology;2013年04期

【相似文獻】

相關(guān)期刊論文 前10條

1 ;Tako-tsubo cardiomyopathy[J];Journal of Nanjing Medical University;2009年03期

2 Ailbhe C O'Neill;Shaunagh McDermott;Carole A Ridge;David Keane;Jonathan D Dodd;;Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 2:Rare phenotypes[J];World Journal of Cardiology;2012年05期

3 Shaunagh McDermott;Ailbhe C O'Neill;Carole A Ridge;Jonathan D Dodd;;Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 1:Common phenotypes[J];World Journal of Cardiology;2012年04期

4 Ivan Mendoza;Gian M Novaro;;Repeat recurrence of takotsubo cardiomyopathy related to inhaled beta-2-adrenoceptor agonists[J];World Journal of Cardiology;2012年06期

5 Joana Cortez;Rui Providência;Evelise Ramos;Cristina Valente;Jorge Seixas;Manuela Meruje;António Leit嗾o-Marques;António Vieira;;Emerging and under-recognized Chagas cardiomyopathy in non-endemic countries[J];World Journal of Cardiology;2012年07期

6 葉飄;譚寧;;Takotsubo cardiomyopathy:A case report[J];South China Journal of Cardiology;2013年03期

7 James D Fett;;Peripartum cardiomyopathy: A puzzle closer to solution[J];World Journal of Cardiology;2014年03期

8 Ardan M Saguner;Corinna Brunckhorst;Firat Duru;;Arrhythmogenic ventricular cardiomyopathy:A paradigm shift from right to biventricular disease[J];World Journal of Cardiology;2014年04期

9 梁光明;Evaluation of Doppler echocardiogr ams on dilated cardiomyopathy in children[J];中國臨床康復;2002年09期

10 ;Troponin I, cardiac diastolic dysfunction and restrictive cardiomyopathy[J];Acta Pharmacologica Sinica;2004年12期

相關(guān)會議論文 前10條

1 ;The value of color Doppler echocardiography on the diagnosis and differential diagnosis of dialated cardiomyopathy[A];第二屆長三角超聲醫(yī)學論壇暨2009年浙江省超聲醫(yī)學學術(shù)年會論文匯編[C];2009年

2 ;Prevention of diabetic cardiomyopathy by metallothionein:experimental evidence possible mechanisms and clinical implication[A];2006年中華醫(yī)學會糖尿病分會第十次全國糖尿病學術(shù)會議論文集[C];2006年

3 ;Explore the treatment for restrictive cardiomyopathy and diastolic dysfunction[A];臨床安全合理用藥的現(xiàn)代生物醫(yī)學理念——中國藥理學會藥學監(jiān)護專業(yè)委員會第一屆第三次學術(shù)大會論文摘要集[C];2007年

4 ;Noninvasive predictive parameters of sudden cardiac death in patients with cardiomyopathy[A];第十三次全國心血管病學術(shù)會議論文集[C];2011年

5 ;Mouse models for restrictive cardiomyopathy due to cTnI mutation and cTnI deficiency[A];生物學時代新藥研發(fā)進展研討會會議資料[C];2006年

6 ;The presence of giant epsilon waves in a patient with arrhythmogenic right ventricular cardiomyopathy[A];第十三次全國心血管病學術(shù)會議論文集[C];2011年

7 Yumei Dong;Zulu Wang;Yanchun Liang;Shibei Li;Ming Liang;Guitang Yang;Zhiqing Jin;Yaling Han;;The Electrophysiologic Characteristics and Radiofrequency Catheter Ablation of Ventricular Arrhythmias in Patients with Cardiomyopathy[A];中華醫(yī)學會第十五次全國心血管病學大會論文匯編[C];2013年

8 ;Ventricular Tachycardia Mediated Cardiomyopathy in a Pregnant Woman with Atrial Septal Defect[A];2009年浙江省心電生理與起搏學術(shù)年會增刊[C];2009年

9 ;Impact of myocardial scar on response to cardiac resynchronization therapy:location or extent[A];第十三次全國心血管病學術(shù)會議論文集[C];2011年

10 洪國|，

本文編號：1979299